- Home
- CDE vs TMDX Comparison
CDE vs TMDX Comparison
Compare CDE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDE
- TMDX
- Stock Information
- Founded
- CDE 1928
- TMDX 1998
- Country
- CDE United States
- TMDX United States
- Employees
- CDE N/A
- TMDX N/A
- Industry
- CDE Precious Metals
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CDE Basic Materials
- TMDX Health Care
- Exchange
- CDE Nasdaq
- TMDX Nasdaq
- Market Cap
- CDE 2.5B
- TMDX 2.1B
- IPO Year
- CDE N/A
- TMDX 2019
- Fundamental
- Price
- CDE $6.17
- TMDX $57.20
- Analyst Decision
- CDE Strong Buy
- TMDX Buy
- Analyst Count
- CDE 4
- TMDX 11
- Target Price
- CDE $7.81
- TMDX $116.10
- AVG Volume (30 Days)
- CDE 9.8M
- TMDX 2.6M
- Earning Date
- CDE 02-19-2025
- TMDX 02-24-2025
- Dividend Yield
- CDE N/A
- TMDX N/A
- EPS Growth
- CDE N/A
- TMDX N/A
- EPS
- CDE N/A
- TMDX 0.94
- Revenue
- CDE $1,010,652,000.00
- TMDX $401,090,000.00
- Revenue This Year
- CDE $32.61
- TMDX $81.61
- Revenue Next Year
- CDE $39.85
- TMDX $22.52
- P/E Ratio
- CDE N/A
- TMDX $61.04
- Revenue Growth
- CDE 31.38
- TMDX 109.09
- 52 Week Low
- CDE $2.42
- TMDX $56.03
- 52 Week High
- CDE $7.72
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- CDE 49.13
- TMDX 35.74
- Support Level
- CDE $5.90
- TMDX $58.40
- Resistance Level
- CDE $6.60
- TMDX $67.80
- Average True Range (ATR)
- CDE 0.30
- TMDX 4.59
- MACD
- CDE 0.04
- TMDX -0.27
- Stochastic Oscillator
- CDE 56.64
- TMDX 4.44
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.